AIDS and diabetic retinopathy.
Kaye-Wilson LG, Fleck BW.
AIDS. 1991 Jul;5(7):902. doi: 10.1097/00002030-199107000-00022.
Retinopathy before the diagnosis of AIDS.
Freeman WR, Henderly DE, Lipson BK, Rao NA, Levine AM.
Ann Ophthalmol. 1989 Dec;21(12):468-74.
Valganciclovir.
Curran M, Noble S.
Drugs. 2001;61(8):1145-50 ; discussion 1151-2. doi: 10.2165/00003495-200161080-00013.
AIDS and ophthalmology: a period of transition.
Jabs DA, Bartlett JG.
Am J Ophthalmol. 1997 Aug;124(2):227-33. doi: 10.1016/s0002-9394(14)70789-5.
A comparative study on retinal thickness of the macular region among AIDS patients with normal ocular fundus, HIV-related microvascular retinopathy patients, and cytomegalovirus retinitis patients.
Xie LY, Chen C, Kong WJ, Du KF, Guo CG, Wei WB.
Medicine (Baltimore). 2019 Jun;98(26):e16073. doi: 10.1097/MD.0000000000016073.
Noninfectious retinopathy.
Harkins T.
Optom Vis Sci. 1995 May;72(5):302-4. doi: 10.1097/00006324-199505000-00005.
Foscarnet sodium.
Minor JR, Baltz JK.
DICP. 1991 Jan;25(1):41-7. doi: 10.1177/106002809102500109.
[Retinal diseases in AIDS].
Hansen LL.
Ophthalmologe. 1993 Jun;90(3):239-49.
Posterior segment manifestations of HIV/AIDS.
Vrabec TR.
Surv Ophthalmol. 2004 Mar-Apr;49(2):131-57. doi: 10.1016/j.survophthal.2003.12.008.
Non-CMV infectious chorioretinopathies in AIDS.
Litwak AB.
Optom Vis Sci. 1995 May;72(5):312-9. doi: 10.1097/00006324-199505000-00008.
